The data shows that during the seven trading days of June 65438+1October 65438+February 20, 800 medical staff (CSI Medical Health Index) increased by 12.38%, of which 14 increased by 7.9 1% a day.
However, many small partners who hold medical theme funds are still not happy.
Someone left a message on the relevant platform saying that his medical theme fund still has 35 points (as of 10-20). Why do some people say that they have returned to books? !
This is actually a very normal thing.
Even if it is the same fund, the income from getting on the bus is different.
If the scope is extended to the fund with the same theme, the subdivision trajectory of heavy positions may be different or the position of the same stock may be high or low, then it is normal for the performance to differ greatly.
In view of this, let's take a look at which funds are in the top of this wave of medical rebound.
First of all, the logic behind the medical rebound
Why did medicine suddenly rebound?
Investigate its reason, the market summed up three aspects.
First, the policy is warm and frequent.
10 6 12, the national medical insurance bureau responded to the proposal of "negotiating drug renewal", focusing on the new "simple renewal" rule set in the national medical insurance negotiation this year.
As early as September this year, the National Medical Insurance Bureau published the "Reply to Recommendation No.4955 of the Fifth Session of the 13th National People's Congress". The "Reply" mentioned that in the process of centralized procurement with quantity, medical institutions determine the purchase quantity according to historical use and combined with clinical use and medical technology progress. Because the clinical use of innovative medical devices is not yet mature, the dosage is difficult to predict for the time being, so the implementation of drug delivery mode is still difficult.
......
The market generally interprets this as that the relevant policies of the pharmaceutical industry tend to be loose.
Second, the pharmaceutical company's third-quarter performance forecast is not bad.
Choice data shows that as of June 10 and June 2 1 day, 48 pharmaceutical companies have disclosed their performance forecasts, and 44 companies have pre-increased, slightly increased and continued their earnings. Among them, Jiu 'an Medical is riding the dust, and its net profit has increased by more than 300 times.
Finally, the valuation, two words: cheap.
Judging from the valuation, as of June 2 1,10,800, the medical PE was valued at 29.04 times, which was located at the valuation quantile of 1 1.72% in the past, which was equal to the time interval of less than 88% in history.
Of course, if we take a long view, we will find another reason, that is, medicine is a "long slope and thick snow" track.
What do you mean? To put it simply, the long-term prospect of the pharmaceutical industry is beyond doubt in the context of the aging population and the improvement of consumption level.
In view of so many benefits, brokers are also actively running out to shout, which generally means that the pharmaceutical sector will continue to rebound at the right time.
Second, it rose nearly 17% in 7 days, which is the best active equity fund.
After talking about the industry, let's talk about funds.
When it comes to medicine, many people think of Glenn.
But in fact, whether it is within 7 days (65438+ 10 month 12 -20, the same below) or 14 day, the best performance is not China Europe Medical Health A.
According to the data, the hardcore fund selected the active equity fund (including common stock fund, partial stock mixed fund and flexible allocation fund) with the largest scale in the fund industry (June 30, 2022), accounting for more than 30% of the net value and the scale exceeding 149 (only calculating A share).
Let's look at the single day of 10+04. The best performer on that day was Jinchuang Hexin Health Care Industry A, with a return rate of 10.52%.
This fund was established from 2065438 to August 2006, with the latest scale (2022-06-30) of 366 million yuan.
Judging from the fund's positions in the second quarterly report, the concentration of its top ten heavyweight stocks is 67.69%, mainly including medical device stocks such as Wan Tai Bio, Aibo Medical and Bairen Medical, as well as medical service stocks such as Medici, Zhao Yan New Drugs and Kaimeiying.
Medical equipment is one of the most dazzling subdivision tracks in this round of medical rebound. The data shows that within seven days from June 28th to October 20th, the CSI medical device index rose by 14.6 1%.
In terms of performance, Jinchuang Hexin Health Care Industry A has fallen by 22.03% since this year (as of 10-20), ranking in the middle of similar funds. However, the total return performance in the past five years and since its establishment is still good, ranking high among its kind.
Next, if the time is extended to 7 days, then the best performing medical fund is the longevity medical industry, with an interval return of 16.72%.
This fund was established from 2065438 to February 2006, with the latest scale (2022-06-30) of 287 million yuan.
Judging from the fund's positions in the second quarterly report, the concentration of its top ten positions is 53.74%, with Huahai Pharmaceutical, Tonghe Pharmaceutical and Beida Pharmaceutical in the chemical pharmaceutical sector as the focus, and WuXi PharmaTech, Kang Longhua Cheng, Jiuzhou Pharmaceutical and Shi Yao Science and Technology in the medical service sector.
It is worth mentioning that this is a quantitative fund, and its strategy is to find high-quality listed companies in the medical industry through qualitative and quantitative analysis.
Zhou Sicong, the fund manager, said in the second quarterly report that he would continue to be optimistic about innovative drugs, traditional Chinese medicines, vaccines, testing, raw materials and medical outsourcing services related to the epidemic.
Let's talk about the dream circle again. Her agricultural bank Huili medical theme is also relatively high in this wave of rebound, with a 7-day increase of 13.79%.
Agricultural Bank of China Huili Medical Theme was established in February 20 15, and the latest scale (June 30, 2022) is 21920,000 yuan. Meng Yuan, the current fund manager, worked in February 20021.
Looking back, the post-90 s fund manager became popular because of a screenshot circulating on the Internet. The screenshot shows that as of March 8, 20021year, that is, Mengyuan only had 12 days, and the best fund withdrawal during his tenure was close to 10%.
Now more than a year has passed, and the total employment return of Mengyuan (as of10-20) is-39.30%, which still lags behind in similar rankings.
Judging from the fund's positions in the second quarterly report, the concentration of its top ten positions is relatively low, accounting for 44.3%, which is lower than the average level of similar positions of 48. 19%. It holds a number of medical service stocks such as Shi Yao Science and Technology, Jiuzhou Pharmaceutical, Boteng and Wuxi PharmaTech.
As for Glen Central Europe Medical Health A, the 7-day increase was 10. 1 1%.
CEIBS Medical Health A was established in September 2006+2065438, with the latest scale (2022-06-30) of 32.586 billion yuan.
In terms of performance, as of June 20 10, Glen's income in the past year was poor, underperforming the broader market. But in the long run, the return in the past five years is 122.90%, while the Shanghai and Shenzhen 300 stocks have fallen by 4.38%.
In the second quarterly report, Gü len expressed long-term optimism about core innovative drugs, innovative devices, innovative industrial chains, medical services and consumer medical care. For short-term poor performance, she suggested that short-term market fluctuations are inevitable.
3. What should I do if the medical fund is not paid back?
In the face of this wave of rebound, many small partners are asking: My medical fund has not been returned. What should I do?
Looking back, the correction of the pharmaceutical sector has been going on for a year. The data shows that the 800 medical health index began to fall all the way after hitting a stage high in February 20021year, which made the medical theme funds in the hands of many small partners fall by more than 30%, 40% or even more.
The more depraved, the more difficult it is to find the roots.
Without adding positions, the fund can recover its capital only if it falls by 25% and rises by 33%; Only by falling 30% and rising 60% can the capital be recovered; If it falls by 40%, it will recover its capital. ......
Therefore, although the medical sector has risen well recently, the medical theme funds in the hands of many people are still far from returning to their original appearance.
The cruel reality has also taught many small partners a lesson: the importance of matching the purchased funds with their own risk preferences.
Why do you say that?
Medicine is indeed recognized as a subject worthy of long-term holding, which is less affected by the economic cycle and has stable demand.
But no one can say for sure the short-term market trend. As we have seen, the decline of the pharmaceutical sector will not be less than that of other popular tracks.
If you can't bear such ups and downs, then once you start, you are likely to eventually "sell at a low point", resulting in a de facto loss.
At present, if you are already in the car and are struggling with how to deal with the medical theme fund that is still losing money, think about how you felt before 10.
If all you feel is pain, then it may be more appropriate to "cut the meat on rallies" to reduce the position.
However, if your position is not heavy and the fluctuation of the sector is acceptable, you may wish to continue to hold it.